Maximum Dose of Melatonin
For adults, the maximum safe dose of melatonin is 10 mg daily for short-term use (≤3 months), though doses up to 15 mg have been studied in specific populations without serious adverse events. 1
Dosing by Clinical Context
For Circadian Rhythm Sleep Disorders (DSWPD, RBD)
Adults:
- Standard dosing: 3-5 mg taken 1.5-2 hours before desired bedtime 1
- Maximum studied dose: Up to 15 mg for REM sleep behavior disorder 2
- Safety threshold: ≤10 mg/daily appears safe for short-term use in healthy adults per National Academy of Sciences review 1
Children/Adolescents:
- Weight-based dosing: 0.15 mg/kg (optimal dose from controlled trials) 1
- Fixed dosing: 3-5 mg for those with psychiatric comorbidities 1
- Maximum studied: Up to 10 mg in pediatric DSWPD patients followed for ~4 years without serious adverse events 1
- Special populations: Up to 15 mg controlled-release studied in neurodevelopmental disabilities for 3.8 years without adverse events 1
For Insomnia
The American Academy of Sleep Medicine recommends AGAINST using melatonin for insomnia treatment (based on 2 mg doses showing insufficient efficacy) 3. However, when used:
- Typical range: 1-6 mg in older adults 4
- Optimal timing: 3 hours before desired bedtime (not 30 minutes) 5
- Optimal dose for sleep promotion: 4 mg/day based on dose-response meta-analysis 5
Safety Profile by Dose
Low-dose (≤3 mg):
- Mimics physiological levels
- Minimal side effects
- Preferred in older adults to avoid supra-physiological levels 6
Moderate-dose (3-6 mg):
- Most commonly studied range
- Well-tolerated in most populations
- Effective for circadian rhythm disorders 1
High-dose (>6-10 mg):
- Associated with increased adverse effects (headaches, somnolence, hypotension, hypertension, GI upset) 1
- May worsen alopecia areata at higher doses 1
- 10 mg studied for 28 days in healthy males without significant adverse effects 1
Very high-dose (>10-15 mg):
- Limited safety data beyond 15 mg
- Used in specialized populations (neurodevelopmental disabilities) under medical supervision 1
Critical Caveats
Populations requiring caution:
- Children/adolescents: Concerns about growth hormone regulation (10 mg dose) and reproductive development (3 mg dose), though long-term studies show no significant pubertal development differences 1
- Women of reproductive age: National Academy of Sciences recommends caution 1
- Patients taking warfarin: Case reports of interactions 1
- Epilepsy patients: WHO case reports suggest caution 1
- Diabetic/prediabetic women: May impair glucose tolerance 1
- Depression: Associated with increased depressive symptoms in some cases 1
Formulation issues:
- Melatonin is a dietary supplement in the U.S., not FDA-regulated 1
- Purity and stated doses vary significantly between products 1
- Use U.S. Pharmacopeial Convention Verified formulations for reliability 1, 2
Practical Algorithm
- Start low: Begin with 3 mg immediate-release formulation
- Time correctly: Administer 1.5-3 hours before desired bedtime (NOT 30 minutes) 1, 5
- Titrate cautiously: Increase by 3 mg increments if inadequate response 2
- Maximum ceiling: Do not exceed 10 mg in routine practice without specialist consultation 1
- Monitor for: Morning sedation, headaches, mood changes, glucose tolerance issues 1
- Duration: Short-term use (≤3 months) has strongest safety evidence; long-term data are limited 1
The evidence strongly supports that higher doses (>10 mg) offer no additional benefit for most indications and increase adverse effect risk, making 10 mg the practical maximum for adults in clinical practice.